Quick Answer
BRAINSTORM CELL THERAPEUTICS INC. reported Research And Development Expense of $4.18 million for the year ending 2025.
- BRAINSTORM CELL THERAPEUTICS INC. showed a decrease of -10.2% in Research And Development Expense from 2024 to 2025.
- This data is from BRAINSTORM CELL THERAPEUTICS INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2012: $369.0 thousand | Q2 2012: $385.0 thousand | Q3 2012: $732.0 thousand | Q1 2013: $522.0 thousand | Q2 2013: $742.0 thousand | Q3 2013: $804.0 thousand | Q1 2014: $680.0 thousand | Q2 2014: $877.0 thousand | Q3 2014: $1.57 million | Q1 2015: $1.25 million | Q2 2015: $1.38 million | Q3 2015: $1.50 million | Q1 2016: $986.0 thousand | Q2 2016: $151.0 thousand | Q3 2016: $790.0 thousand | Q1 2017: $941.0 thousand | Q2 2017: $435.0 thousand | Q3 2017: $1.17 million | Q1 2018: $977.0 thousand | Q2 2018: $1.48 million | Q3 2018: $1.98 million | Q1 2019: $3.46 million | Q2 2019: $3.55 million | Q3 2019: $4.01 million | Q1 2020: $5.95 million | Q2 2020: $5.69 million | Q3 2020: $1.87 million | Q1 2021: $4.34 million | Q2 2021: $3.60 million | Q3 2021: $3.62 million | Q1 2022: $2.62 million | Q2 2022: $5.11 million | Q3 2022: $3.78 million | Q1 2023: $2.92 million | Q2 2023: $2.79 million | Q3 2023: $3.33 million | Q1 2024: $961.0 thousand | Q2 2024: $922.0 thousand | Q3 2024: $1.05 million | Q1 2025: $1.30 million | Q2 2025: $1.12 million | Q3 2025: $899.0 thousand.
- Over the full 16 years of available data (2010 to 2025), BRAINSTORM CELL THERAPEUTICS INC.'s Research And Development Expense has grown by 299.5%.
- Historical annual values: Fiscal year 2025: $4.18 million | Fiscal year 2024: $4.65 million | Fiscal year 2023: $10.75 million | Fiscal year 2022: $13.96 million | Fiscal year 2021: $15.24 million | Fiscal year 2020: $22.33 million | Fiscal year 2019: $17.20 million | Fiscal year 2018: $8.29 million | Fiscal year 2017: $977.0 thousand | Fiscal year 2016: $2.25 million | Fiscal year 2015: $4.95 million | Fiscal year 2014: $4.77 million | Fiscal year 2013: $2.92 million | Fiscal year 2012: $1.77 million | Fiscal year 2011: $1.69 million | Fiscal year 2010: $1.05 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: